
浏览全部资源
扫码关注微信
川北医学院:附属医院检验科,检验系2005级,检验系
纸质出版日期:2011,
网络出版日期:2011-10-30,
移动端阅览
凡瞿明, 刘秋月, 张子夏, 等. 抗C1q抗体及抗ENA抗体与系统性红斑狼疮疾病活动和肾脏受累的关系[J]. 陆军军医大学学报, 2011,33(20):2128-2131.
FAN QUMING, LIU QIUYUE, ZHANG ZIXIA, et al. Relationship of anti-C1q antibodies and anti-ENA antibodies with disease activity and nephric impairment in systemic lupus erythematosus. [J]. Journal of army medical university, 2011, 33(20): 2128-2131.
凡瞿明, 刘秋月, 张子夏, 等. 抗C1q抗体及抗ENA抗体与系统性红斑狼疮疾病活动和肾脏受累的关系[J]. 陆军军医大学学报, 2011,33(20):2128-2131. DOI:
FAN QUMING, LIU QIUYUE, ZHANG ZIXIA, et al. Relationship of anti-C1q antibodies and anti-ENA antibodies with disease activity and nephric impairment in systemic lupus erythematosus. [J]. Journal of army medical university, 2011, 33(20): 2128-2131. DOI:
目的 探讨系统性红斑狼疮(systemic lupus erythematosus,SLE)患者血清中抗C1q 抗体及抗ENA抗体与SLE疾病活动状态和肾脏受累的关系,揭示抗C1q 抗体、抗ENA抗体在疾病诊断及评判中的临床价值。 方法 将来自本院123例SLE患者按疾病活动状态以及是否满足狼疮性肾炎(lupus nephritis
LN)诊断条件分为LN活动组、非LN活动组、LN稳定组和非LN稳定组。患者24 h内收集血、尿标本,分别用ELISA法检测抗C1q抗体;斑点印迹法检测抗ENA抗体;干式化学法检测尿蛋白;用全自动生化分析仪检测血β
2
微球蛋白(β
2
-MG)和肌酐(CREA)。 结果 β
2
-MG阳性率:LN活动组与非LN活动组(88.6%
vs
59.4%)、LN稳定组与非LN稳定组(66.1%
vs
47.4%)比较差异有统计学意义(
P
<
0.05
P
<
0.01);CREA阳性率:LN稳定组与非LN稳定组相比差异有显著性(27.8%
vs
0.0%
P
<
0.01);尿蛋白“++++” 阳性率:LN活动组(42.9%)与非LN活动组(12.5%)、非LN稳定组(2.6%)比较差异有统计学意义(
P
<
0.05,
P
<
0.01);抗C1q抗体阳性率:LN活动组与非LN稳定组相比差异有统计学意义(68.6%
vs
36.8%
P
<
0.05)。抗C1q抗体阳性与阴性组间尿蛋白“++++” 、“+”阳性率比较差异有显著性(26.2%
vs
11.3%,14.8%
vs
38.7%,
P
<
0.05)。 结论 SLE患者肾脏损害常发生于疾病活动期,抗C1q抗体和部分抗ENA抗体可能是加重肾脏损害的因素。实验室监测抗C1q抗体及β
2
-MG的水平对预测SLE患者肾脏损害有积极指导意义。
Objective To investigate the relation
ship of serum anti-C1q antibodies and anti-extractable nuclear antigen (anti-ENA) antibodies with disease activity and nephric impairment in systemic lupus erythematosus (SLE) for clinical values of the 2 antibodies in diagnosis and evaluation of the disease. Methods A total of 123 cases of SLE patients who admitted in our hospital in recent 1 year were divided into 4 groups according to SLE activity and lupus nephritis (LN)
that is
LN activity group (
n
=35); non-LN activity group(
n
=32); LN stable group (
n
=18) and non-LN stable group (
n
=38). Serum and urine specimens of SLE patients was collected within 24 h of first hospitalization. Anti-C1q antibodies were detected by ELISA
and anti-ENA antibodies were assayed by dot blotting. Dry chemistry method was used to detect urinary protein. β
2
-microglobulin (β
2
-MG) and creatinine (CREA) was assayed using the automatic biochemical analyzer. Results β
2
-MG positive rate in LN activity group (88.6%) was significantly higher than non-LN activity group(59.4%)and LN stable group(66.1%)(both
P
<
0.05)
and was still significantly higher than non-LN stable group(47.4%)(
P
<
0.01). The positive rate of CREA in stable group of LN (27.8%)was significantly higher than stable group of non-LN(0.0%)(
P
<
0.01). Urine protein characterized as “++++” positive rate in LN activity group(42.9%)was significantly higher than non-LN activity group(12.5%)and non-LN stable group(2.6%)(
P
<
0.05
0.01). Anti-C1q antibody positive rate was significantly higher in LN activity group (68.8%) than in non-LN stable group (36.8%)(
P
<
0.05). Significant differences were found in urinary protein as a “++++” and “+” positive rate in anti-C1q antibody-negative group and the anti-C1q antibody positive group (26.2%
vs
11.3%,14.8%
vs
38.7%,
P
<
0.05). Conclusion In SLE patients
nephric impairment occur when disease in activity
. Presence of anti-C1q antibodies and anti-ENA antibodies may aggravate the impairment. And to those patients
standard monitoring of anti-C1q antibodies and β
2
-MG is of significance to forecast the kidney damage.
C1q,抗体系统性红斑狼疮狼疮肾炎
C1q,antibodysystemic lupus erythematosuslupus nephritis
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621